UK cost agency says 'no' to Bayer prostate cancer drug Xofigo
LONDON (Reuters) - Britain's healthcare cost agency has recommended against using Bayer's new prostate cancer drug Xofigo on the state health service ...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/bKH3X-eB8-s/story01.htm
No comments:
Post a Comment